Tyrosine kinases

May 27, 2020

Sierra Oncology Announces Presentations at Upcoming Investor Conferences

Mar 24, 2020

Chipscreen Biosciences's Original New Drug CS12192: Investigational New Drug (IND) Application Accepted

Feb 25, 2020

Sierra Oncology to Present at the Cowen 40th Annual Health Care Conference

Nov 14, 2019

Sierra Oncology to Present at the Jefferies 2019 London Healthcare Conference

Sep 03, 2019

Selvita to Present at Upcoming Conferences in September

Jul 08, 2019

Calquence (acalabrutinib; AstraZeneca/Acerta) Markets, 2017-2026: A Novel, Orally Available, Second-Generation Bruton's Tyrosine Kinase Inhibitor with Potential Antineoplastic Activity

Oct 22, 2018

Reistone Biopharma, a new Chinese biotech company ready to initiate its Ulcerative Colitis phase II clinical trial globally

Jun 20, 2018

Rigel Announces Poster Presentations at FOCIS Annual Meeting

Feb 26, 2018

Proto Oncogene Market & Clinical Pipeline Insight 2024

Sep 04, 2017

Tyrosine Protein Kinase CSK (C Src Kinase or Protein Tyrosine Kinase CYL or CSK or EC 2.7.10.2) - Pipeline Review, H2 2017